Press Releases

Aptar Reports Third Quarter 2021 Results

Aptar today reported third quarter results for 2021.

28 Oct 2021

Crystal Lake, Illinois, October 28, 2021 — AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter results for 2021.

Third Quarter 2021 Summary

  • Reported sales grew 9%, primarily driven by double-digit core sales growth in Beauty + Home and Food + Beverage from a combination of price increases and volume growth
  • Core sales (excluding currency effects) increased 8%
  • Pharma sales declined slightly compared to the prior year
  • Reported earnings per share totaled $0.70 and included restructuring charges ($0.12), an unrealized loss on an equity investment ($0.10) resulting from the mark-to-market position of our investment in PureCycle Technologies, Inc. (purification recycling technology) and acquisition costs ($0.02)
  • Adjusted earnings per share, excluding restructuring charges, the loss on the equity investment and acquisition costs, totaled $0.94
  • Reported net income totaled $47 million
  • Adjusted EBITDA totaled $154 million
  • Acquisition Updates:
    • Completed the acquisition of 80% of Weihai Hengyu Medical Products, adding elastomeric and plastic component manufacturing capabilities in China for injectable drug delivery
    • Completed the acquisition of a majority stake in Voluntis, a provider of digital therapeutic solutions

Download the full press release

Back To Top